PGDS

All (3) PGDS Inhibitors (3)

Catalog No.	Information	Product Use Citations	Product Validations
S9678^New	AT-56 AT-56 is an orally active and selective inhibitor of lipocalin-type prostaglandin (PG) D synthase (L-PGDS) with Ki of 75 μM and IC50 of 95 μM.
S0192	HPGDS inhibitor 1 HPGDS inhibitor 1 is a novel and selective inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS) with IC50 of 0.7 nM.
S0484	GSK-2894631A GSK2894631A is an inhibitor of hematopoietic PGD synthase (HPGDS).

Catalog No.

Information

Product Use Citations

Product Validations

S9678^New

AT-56 is an orally active and selective inhibitor of lipocalin-type prostaglandin (PG) D synthase (L-PGDS) with Ki of 75 μM and IC50 of 95 μM.

S0192

HPGDS inhibitor 1 is a novel and selective inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS) with IC50 of 0.7 nM.

S0484

GSK2894631A is an inhibitor of hematopoietic PGD synthase (HPGDS).

Catalog No.	Information	Product Use Citations	Product Validations
S9678^New	AT-56 AT-56 is an orally active and selective inhibitor of lipocalin-type prostaglandin (PG) D synthase (L-PGDS) with Ki of 75 μM and IC50 of 95 μM.
S0192	HPGDS inhibitor 1 HPGDS inhibitor 1 is a novel and selective inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS) with IC50 of 0.7 nM.
S0484	GSK-2894631A GSK2894631A is an inhibitor of hematopoietic PGD synthase (HPGDS).